Sporadic Inclusion Body Myositis clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 40 years and up
This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits total). We will include 150 participants, enrolled across 13 sites, with sporadic IBM, diagnosed according to established criteria.
at UC Irvine UCLA
Our lead scientists for Sporadic Inclusion Body Myositis research studies include Tahseen Mozaffar, MD FAAN, FANA.